Current stage-Stage III Posts on Medivizor
Navigation Menu

Current stage-Stage III Posts on Medivizor

Evaluating the outcomes of prophylactic cranial irradiation for the treatment of non-small cell lung cancer with a high-risk of developing brain metastases

Evaluating the outcomes of prophylactic cranial irradiation for the treatment of non-small cell lung cancer with a high-risk of developing brain metastases

Posted by on Apr 30, 2021 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness and outcomes of using prophylactic cranial irradiation (PCI) in patients with non-small cell lung cancer (NSCLC) with a high risk for developing brain metastases (BM). The data showed that PCI significantly decreased the risk of developing BM and increased the overall survival in these...

Read More

Evaluating the outcomes and safety of radiotherapy after immediate breast reconstruction following breast-conserving surgery

Evaluating the outcomes and safety of radiotherapy after immediate breast reconstruction following breast-conserving surgery

Posted by on Apr 30, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness and safety outcomes of radiotherapy (RT) after immediate autologous breast reconstruction (IABR) following breast-conserving surgery (BCS) in patients with breast cancer. The data showed that RT following IABR provided aesthetically satisfactory results with manageable side effects in these...

Read More

Evaluating a cancer vaccine as post-surgery therapy for patients with advanced melanoma

Evaluating a cancer vaccine as post-surgery therapy for patients with advanced melanoma

Posted by on Apr 25, 2021 in Melanoma | 0 comments

In a nutshell The aim of this study was to evaluate the safety and effectiveness of a cancer vaccine for patients with advanced melanoma. The study found that the vaccine was safe and increased patient survival without worsening of the disease. Some background Treatment for early-stage melanoma includes surgery to remove the tumor. For...

Read More

Chemotherapy versus endocrine therapy before surgery for invasive ductal carcinoma of the breast

Chemotherapy versus endocrine therapy before surgery for invasive ductal carcinoma of the breast

Posted by on Apr 18, 2021 in Breast cancer | 0 comments

In a nutshell This study aimed to compare the effectiveness and safety of endocrine therapy (ET) or chemotherapy (CT) before surgery in patients with invasive ductal carcinoma (IDC) of the breast that is hormone receptor (HR) positive (+) and human epidermal growth factor receptor 2 (ERBB2) negative (-). The study concluded CT before...

Read More

Evaluating treatment options after surgery for patients with high-risk melanoma.

Evaluating treatment options after surgery for patients with high-risk melanoma.

Posted by on Apr 11, 2021 in Melanoma | 0 comments

In a nutshell The aim of this study was to evaluate different types of therapy after surgery for patients with high-risk melanoma. The study found that add-on targeted therapy or immunotherapy was likely to decrease the risk of disease progression in these patients. Some background Melanoma is a form of skin cancer. Treatment for early-stage...

Read More

Comparing the long-term effectiveness of integrated IMRT vs segmented 3D-CRT after modified breast removal surgery in breast cancer patients

Comparing the long-term effectiveness of integrated IMRT vs segmented 3D-CRT after modified breast removal surgery in breast cancer patients

Posted by on Apr 3, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the long-term effectiveness of integrated intensity-modulated radiation therapy (IMRT) and segmented 3D-conventional radiotherapy (3D-CRT) following breast-removal surgery (radical mastectomy) in patients with breast cancer (BC). The data showed that integrated IMRT reduced the recurrence rate in the long-term with...

Read More

Evaluating S-1 plus cisplatin with radiotherapy for inoperable stage III non-small cell lung cancer

Evaluating S-1 plus cisplatin with radiotherapy for inoperable stage III non-small cell lung cancer

Posted by on Feb 25, 2021 in Lung cancer | 0 comments

In a nutshell This study looked at the use of chemotherapy with S-1 (Teysuno) plus cisplatin (Platinol) versus docetaxel (Taxotere) plus cisplatin and radiotherapy (RT) for stage III non-small-cell lung cancer (NSCLC) that cannot be surgically removed. The authors found that S-1 plus cisplatin (SP) should be considered as a treatment...

Read More

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Posted by on Feb 6, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the role of circulating tumor cells (CTCs) in deciding adjuvant therapy (AT; treatment after surgery) in patients with breast cancer (BC). This study showed that personalized AT based on CTCs improved patient survival. Some background BC that has not spread to other areas of the body is called non-metastatic...

Read More

Looking for patients with HER-2 positive advanced breast cancer to trial an experimental treatment.

Looking for patients with HER-2 positive advanced breast cancer to trial an experimental treatment.

Posted by on Jan 28, 2021 in Breast cancer | 0 comments

In a nutshell This trial is aiming to examine the safety and effectiveness of an experimental treatment called BPX-063, a CAR-T cell treatment, in patients with advanced HER-2 positive breast cancer. The main outcomes to be measured are the maximum tolerated dose of BPX-603 and the antitumor activity. This trial is being carried out across the...

Read More

Bevacizumab combined with first-line chemotherapy for metastatic colorectal cancer in a real-world setting

Bevacizumab combined with first-line chemotherapy for metastatic colorectal cancer in a real-world setting

Posted by on Jan 19, 2021 in Colorectal cancer | 0 comments

In a nutshell This article looked at the effectiveness of bevacizumab (Avastin) with chemotherapy for metastatic colorectal cancer (mCRC) in a real-world setting. The authors found that the addition of bevacizumab to chemotherapy regimens provides survival benefits in patients who cannot undergo curative local treatment. Some background...

Read More

Evaluating erlotinib plus radiotherapy for stage 3, EGFR-positive non-small cell lung cancer that cannot be surgically removed

Evaluating erlotinib plus radiotherapy for stage 3, EGFR-positive non-small cell lung cancer that cannot be surgically removed

Posted by on Jan 17, 2021 in Lung cancer | 0 comments

In a nutshell This trial was carried to look at the use of erlotinib (Tarceva) with radiotherapy (RT) compared to standard treatment for EGFR-positive non-small cell lung cancer (NSCLC) that cannot be removed surgically. The authors found that erlotinib and RT improved survival without cancer worsening in these patients. Some...

Read More